AOTI, Inc. engages in the development and sale of medical solutions for chronic wounds. The company is headquartered in Oceanside, California and currently employs 120 full-time employees. The company went IPO on 2024-06-18. The firm is focused on helping all people with chronic conditions get back to living their lives to the fullest. The company does this by enhancing access to care, improving clinical outcomes and quality of life, and advancing health equity. Its products are built with integrity and backed by robust clinical evidence, ensuring safety and efficacy for its patients. Its solutions include Topical Wound Oxygen (TWO2) and NEXA Negative Pressure Wound Therapy (NPWT). TWO2 therapy is a multi-modality patient-administered therapy. TWO2 is a clinically proven therapy for the treatment of chronic and difficult-to-heal wounds. The NEXA NPWT System is a multi-week, multi-patient, disposable system that delivers the performance and flexibility of traditional NPWT systems. TWO2 therapy solutions include TWO2 Extremity Chamber and TWO2 Multi-Patch.